Net Medical Announces Strategic Partnership with Accorto Regulatory Solutions

ALBUQUERQUE, NM / ACCESSWIRE / June 21, 2022 / Further broadening its FDA Clinical Trials program.Net Medical (OTC PINK:NMXS) announced today a new strategic partnership with Accorto Regulatory Solutions.Dick Govatski, CEO, Net Medical said, "We're expanding our CLIA Moderate Complex Lab to assist regulatory firms with human factor studies and clinical trials for virus tests.

The copyright of this article belongs to the original author/organization.

The current content only represents the author’s point of view, and has nothing to do with the position of Longbridge. The content is for investment reference only and does not constitute any investment advice. If you have any questions or suggestions about the content services provided by Longbridge, please contact: editorial@longbridge.global